Published in Br J Haematol on October 24, 2011
Central nervous system imaging in childhood Langerhans cell histiocytosis - a reference center analysis. Radiol Oncol (2015) 0.85
New insights into the molecular pathogenesis of langerhans cell histiocytosis. Oncologist (2014) 0.83
Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning. Br J Haematol (2015) 0.82
BRAF gene: From human cancers to developmental syndromes. Saudi J Biol Sci (2014) 0.81
Personalized medicine in hematology - A landmark from bench to bed. Comput Struct Biotechnol J (2014) 0.80
Interstitial lung diseases-can pathologists arrive at an etiology-based diagnosis? A critical update. Virchows Arch (2012) 0.80
Langerhans' cell histiocytosis of the temporal fossa: A case report. Oncol Lett (2016) 0.75
Hydroxyurea: a new old therapy for Langerhans cell histiocytosis. Blood (2016) 0.75
Diabetes Insipidus and Sclerosing Cholangitis in a child may be a clue to the diagnosis of Langerhans' Cell Histiocytosis: A Case Report. Int J Health Sci (Qassim) (2013) 0.75
An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis. BMJ Case Rep (2012) 0.75
Langerhans cell histiocytosis: Current concepts in dentistry and case report. J Clin Exp Dent (2016) 0.75
Swelling of bilateral parotid glands: An unusual symptom of multisystem Langerhans cell histiocytosis. SAGE Open Med Case Rep (2014) 0.75
BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay. Diagn Pathol (2016) 0.75
A T Cell View of the Bone Marrow. Front Immunol (2016) 0.75
[Pulmonary Langerhans cell histiocytosis]. Pathologe (2015) 0.75
Molecular analysis of BRAF V600E mutation in multiple nodules of pulmonary Langerhans cell histiocytosis. Virchows Arch (2017) 0.75
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med (2003) 6.61
Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood (2010) 4.96
Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A (2007) 4.81
Inactivation of the p53 pathway in retinoblastoma. Nature (2006) 4.57
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res (2005) 4.14
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood (2009) 3.37
Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. J Clin Oncol (2014) 2.67
Physicians' attitudes about multiplex tumor genomic testing. J Clin Oncol (2014) 2.62
Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes (2007) 2.54
Carboplatin-associated ototoxicity in children with retinoblastoma. J Clin Oncol (2012) 2.32
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood (2009) 2.28
Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol (2009) 2.26
Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): a model for sustainable development in pediatric oncology. Pediatr Blood Cancer (2013) 2.23
Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest (2012) 2.15
Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation (2007) 2.14
CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol (2004) 2.11
Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation (2003) 2.11
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia. Blood (2008) 2.10
Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res (2012) 2.06
The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol (2004) 1.88
Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell (2004) 1.81
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Invest (2011) 1.74
Utility of FDG-PET scanning in lymphoma by WHO classification. Blood (2003) 1.69
Coexpression of normally incompatible developmental pathways in retinoblastoma genesis. Cancer Cell (2011) 1.67
Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. Am J Ophthalmol (2005) 1.64
Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer (2007) 1.62
Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer (2012) 1.60
c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol Cell Biol (2003) 1.59
MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci U S A (2011) 1.54
Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma. Ophthalmology (2009) 1.54
Incidence of childhood and adolescent melanoma in the United States: 1973-2009. Pediatrics (2013) 1.52
Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis (2011) 1.49
World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer (2008) 1.48
Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients. Cancer (2009) 1.45
Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. Clin Lymphoma (2004) 1.44
Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes. Am J Hematol (2005) 1.43
Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group. Pediatr Blood Cancer (2014) 1.41
DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras. Oncogene (2003) 1.39
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma. Blood (2009) 1.39
Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma. Cancer (2010) 1.33
Use of preclinical models to improve treatment of retinoblastoma. PLoS Med (2005) 1.31
Pathogenesis of Langerhans cell histiocytosis. Annu Rev Pathol (2012) 1.31
Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol (2007) 1.30
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Cancer (2004) 1.29
Metastatic osteosarcoma. Cancer (2006) 1.27
PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Radiol (2007) 1.24
Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood (2005) 1.24
Reducing irinotecan-associated diarrhea in children. Pediatr Blood Cancer (2008) 1.22
Second malignancies in patients with Ewing Sarcoma Family of Tumors: A population-based study. Acta Oncol (2010) 1.22
Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer (2010) 1.22
UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan. J Clin Oncol (2007) 1.20
Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J Immunol (2003) 1.15
Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database. Pediatr Blood Cancer (2011) 1.14
The International Pediatric Adrenocortical Tumor Registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors. Mol Cell Endocrinol (2011) 1.13
The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J Immunol (2006) 1.10
MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes Chromosomes Cancer (2015) 1.10
Neuronal differentiation and synaptogenesis in retinoblastoma. Cancer Res (2007) 1.10
Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer (2013) 1.10
MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (2002) 1.08
Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors. Cancer (2005) 1.08
Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. J Neurosci (2002) 1.08
MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells. J Leukoc Biol (2004) 1.07
Absence of CC chemokine ligand 2 results in an altered Th1/Th2 cytokine balance and failure to expel Trichuris muris infection. J Immunol (2003) 1.06
Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. Virology (2004) 1.06
Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum (2008) 1.05
Infections in children and young adults with bone malignancies undergoing limb-sparing surgery. Cancer (2005) 1.04
CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture. J Immunol (2005) 1.03
Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. Oncol Nurs Forum (2007) 1.01
Caveolin-1 modulates the ability of Ewing's sarcoma to metastasize. Mol Cancer Res (2010) 1.01
Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. FASEB J (2005) 1.01
Team management, twinning, and telemedicine in retinoblastoma: a 3-tier approach implemented in the first eye salvage program in Jordan. Pediatr Blood Cancer (2008) 1.00
Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma. Cancer Res (2006) 0.99
Clinical field testing of an enhanced-activity intervention in hospitalized children with cancer. J Pain Symptom Manage (2007) 0.99
Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death. Sci Transl Med (2011) 0.98
Differential features of nasopharyngeal carcinoma in children and adults: a SEER study. Pediatr Blood Cancer (2010) 0.97
Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma. Pediatr Blood Cancer (2013) 0.97
PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging (2012) 0.96
Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation. Am J Surg Pathol (2008) 0.96
Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes. Cytometry B Clin Cytom (2005) 0.96
A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma. Br J Ophthalmol (2010) 0.96
Second cancers in patients with the Ewing sarcoma family of tumours. Eur J Cancer (2008) 0.96
Ewing sarcoma-family tumors that arise after treatment of primary childhood cancer. Cancer (2006) 0.95
Salivary gland carcinomas in children and adolescents: a population-based study, with comparison to adult cases. Head Neck (2010) 0.95
Langerhans cell histiocytosis: malignancy or inflammatory disorder doing a great job of imitating one? Dis Model Mech (2009) 0.95
Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells. Int J Cancer (2003) 0.95
Episcleral plaque brachytherapy for retinoblastoma. Pediatr Blood Cancer (2004) 0.95
Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers. Cancer (2013) 0.94
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors. J Clin Oncol (2006) 0.94
Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors. J Clin Oncol (2009) 0.94
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. J Clin Endocrinol Metab (2006) 0.94
The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo. J Immunol (2010) 0.94
Trilateral retinoblastoma: potentially curable with intensive chemotherapy. Pediatr Blood Cancer (2010) 0.94
Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. Am J Hematol (2008) 0.93
Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood (2003) 0.93
MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury. Biochem Biophys Res Commun (2003) 0.93
Primary malignant peripheral nerve sheath tumor of the lung in a young child without neurofibromatosis type 1. Pediatr Blood Cancer (2006) 0.93
Treating Pediatric soft tissue sarcomas in a country with limited resources: the experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala. Pediatr Blood Cancer (2008) 0.93